Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “pMN”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03793205
What this trial is testing

G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients

Who this might be right for
Gynecologic CancerMyelosuppression AdultFebrile Neutropenia+1 more
Lei Li 100
Testing effectiveness (Phase 2)Study completedNCT00651937
What this trial is testing

Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

Who this might be right for
Multiple MyelomaPrimary Amyloidosis
M.D. Anderson Cancer Center 80
Early research (Phase 1)Study completedNCT00002009
What this trial is testing

A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

Who this might be right for
HIV InfectionsCytopenias
Sandoz
Testing effectiveness (Phase 2)Ended earlyNCT00477087
What this trial is testing

Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Stanford University 10
Not applicableStudy completedNCT00000896
What this trial is testing

Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00076037
What this trial is testing

Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Not applicableLooking for participantsNCT06708572
What this trial is testing

Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia

Who this might be right for
Granulocyte Colony-stimulating FactorBiliary Atresia
National Liver Institute, Egypt 40
Large-scale testing (Phase 3)UnknownNCT03665480
What this trial is testing

The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AML

Who this might be right for
Granulocyte Colony-stimulating FactorMinimal Residual DiseaseAcute Myeloid Leukemia
Nanfang Hospital, Southern Medical University 122
Testing effectiveness (Phase 2)Study completedNCT02465801
What this trial is testing

Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein

Who this might be right for
Chemotherapy-induced Neutropenia
Tianjin SinoBiotech Ltd. 216
Not applicableStudy completedNCT01805180
What this trial is testing

Evaluation of the Spectra Optia PMN Cell Collection Procedure

Who this might be right for
Granulocyte/ Polymorphonuclear Cells
Terumo BCT 42
Post-approval studies (Phase 4)Study completedNCT02451488
What this trial is testing

Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma

Who this might be right for
Melanoma
Mayo Clinic 8
Early research (Phase 1)Study completedNCT00001269
What this trial is testing

Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Looking for participantsNCT04050280
What this trial is testing

CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

Who this might be right for
Acute Myeloid Leukemia, AdultAcute Myeloid Leukemia RecurrentAcute Myeloid Leukemia, Relapsed, Adult
University of Maryland, Baltimore 39
Not applicableStudy completedNCT01901458
What this trial is testing

Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®

Who this might be right for
Healthy Allogeneic DonorsGranulocyte Colony-stimulating Factor (G-CSF) Mobilized
Heinrich-Heine University, Duesseldorf 50
Testing effectiveness (Phase 2)Study completedNCT00082329
What this trial is testing

G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers

Who this might be right for
Healthy
National Heart, Lung, and Blood Institute (NHLBI) 9
Early research (Phase 1)Study completedNCT00487305
What this trial is testing

Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Dana-Farber Cancer Institute 24
Large-scale testing (Phase 3)Ended earlyNCT00133302
What this trial is testing

Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)

Who this might be right for
Non-Hodgkin's Lymphoma
Japan Clinical Oncology Group 450
Testing effectiveness (Phase 2)Study completedNCT01617577
What this trial is testing

Efficacy and Safety of Filgrastim in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
University of South Florida 8
Not applicableUnknownNCT03776604
What this trial is testing

PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy

Who this might be right for
Small Cell Lung CancerPEG-rhG-CSF
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 61
Testing effectiveness (Phase 2)Ended earlyNCT00058747
What this trial is testing

AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™

Who this might be right for
Leukemia, Myeloid, Chronic
Agenus Inc. 40
Next Page